The molecular connections between the cannabinoid system and endometriosis
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
The endocannabinoid system consists of an array of endogenously produced bioactive lipids that activate cannabinoid 1 (CB1) and 2 (CB2) receptors. Alterations of this system have been described in almost every category of disease. These changes can be protective or maladaptive, making the endocannabinoid network an attractive therapeutic target. Little is known about the potential role of endocannabinoids in endometriosis development although this is a topic worthy of further investigation since endocannabinoid modulators have recently been shown to affect specific mechanisms critical to endometriosis establishment and maintenance. A literature review was herein performed with the aim of defining the regulation and function of the endocannabinoid signaling in in vitro and animal models of endometriosis. The components of the endocannabinoid system, CB1 and CB2 receptors and the enzymes N-acylphosphatidylethanolamine-phospholipase D and fatty acid amide hydrolase are differentially regulated throughout the menstrual cycle in the endometrium and are expressed in deep endometriotic nodules and in sensory and sympathetic neurons innervating the lesions. Selective cannabinoid receptor agonists, such as WIN 55212-2, appear to have a favorable action in limiting cell proliferation and in controlling pain symptoms. Conversely, endometrial cell migration tends to be stimulated by receptor agonists. The phosphatidylinositol 3-kinase/Akt and extracellular signal-regulated kinase 1/2 pathways seem to be involved in these processes. However, the underlying mechanisms of action are only just beginning to unfold. Given the complexity of the system, further studies are needed to clarify whether the endocannabinoid system might represent a promising target for endometriosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The endocannabinoid system and its therapeutic exploitation
Marzo, V. D., Bifulco, M., & Petrocellis, L. D. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1495 · Cited by 1,090 · cited 1×
“Anandamide is synthesized from its precursor N-acylphosphatidylethanolamine (NAPE) by the NAPEphospholipase D (NAPE-PLD) (Di Marzo et al., 2004).”
BackgroundCannabinoid physiology and pharmacology: 30 years of progress
Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., & Porrino, L. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.030 · Cited by 608 · cited 2×
“…and basal ganglia), memory and cognition (cortex and hippocampus), emotion (amygdala), sensory perception (thalamus) and in the hypothalamus, pons and medulla but also in other tissues such as testis, eye, vascular endothelium, spleen and uterus (Howlett et al., 2004; Venance et al., 2004).”
BackgroundCannabinoids as Novel Anti-Inflammatory Drugs
Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009) · Future Medicinal Chemistry · doi:10.4155/fmc.09.93 · Cited by 555 · cited 2×
“…apparently most of their pro-inflammatory effects seem to be attributable to the expression of CB1 receptors, it is likely that the clinical promise of cannabinoids as anti-inflammatory drugs may be fulfilled only with the development of highly selective CB2 agonists (Nagarkatti et al., 2009).”
BackgroundChronic pelvic pain and endometriosis: translational evidence of the relationship and implications
Stratton, P., & Berkley, K. J. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq050 · Cited by 442 · cited 2×
“– According to Taylor et al. (2010a), CB1 receptor immunoreactivity was more intense in the glandular epithelium compared with the stroma and its expression was not regulated throughout the menstrual cycle.”
BackgroundEmerging strategies for exploiting cannabinoid receptor agonists as medicines
Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436 · cited 2×
“Cannabinoids and modulators of the endocannabinoid system have recently been shown to affect specific mechanisms (inflammation, cell proliferation and cell survival) that are critical to endometriosis establishment and maintenance (Pertwee, 2009).”
BackgroundEndometriosis and Mechanisms of Pelvic Pain
Howard, F. M. (2009) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2009.06.017 · Cited by 218 · cited 1×
“Three mechanisms, nociceptive, inflammatory and neuropathic, seem to be relevant to endometriosis-associated pelvic pain (Howard, 2009).”
BackgroundEndometriosis: Current Therapies and New Pharmacological Developments
Vercellini, P., Somigliana, E., Viganò, P., Abbiati, A., Barbara, G., & Crosignani, P. G. (2009) · Drugs · doi:10.2165/00003495-200969060-00002 · Cited by 182
Self-citation“Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis
Vercellini, P., Crosignani, P., Somigliana, E., Vigano, P., Frattaruolo, M. P., & Fedele, L. (2011) · Human Reproduction · doi:10.1093/humrep/deq302 · Cited by 180 · cited 1×
“However, results with this target were less clinically promising than previously envisioned, mostly because of the need to use other compounds in association with aromatase inhibitors during treatment (Vercellini et al., 2011).”
BackgroundSelf-citationAnti-TNF- treatment for deep endometriosis-associated pain: a randomized placebo-controlled trial
Koninckx, P. R., Craessaerts, M., Timmerman, D., Cornillie, F., & Kennedy, S. (2008) · Human Reproduction · doi:10.1093/humrep/den177 · Cited by 165 · cited 1×
“Other therapeutic targets derived from the molecular analysis of the endometriotic lesions have received some attention but limited subsequent development (Lebovic et al., 2010) or have failed in preliminary clinical trials (Koninckx et al., 2008).”
BackgroundEndocannabinoids and pregnancy.
Taylor, A. H., Amoako, A. A., Bambang, K., Karasu, T., Gebeh, A., Lam, P. M. W., Marzcylo, T. H., & Konje, J. C. (2010) · Clinica Chimica Acta · doi:10.1016/j.cca.2010.03.012 · Cited by 89
Cited by
Endometriosis: Etiology, pathobiology, and therapeutic prospects
Saunders, P. T. K., & Horne, A. W. (2021) · Cell · doi:10.1016/j.cell.2021.04.041 · Cited by 961
From pathogenesis to clinical practice: Emerging medical treatments for endometriosis
Clemenza, S., Sorbi, F., Noci, I., Capezzuoli, T., Turrini, I., Carriero, C., Buffi, N., Fambrini, M., & Petraglia, F. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.021 · Cited by 63
The clinical significance of endocannabinoids in endometriosis pain management
Bouaziz, J., Bar On, A., Seidman, D. S., & Soriano, D. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0035 · Cited by 65
Neurogenic Inflammation in the Context of Endometriosis—What Do We Know?
Velho, R. V., Taube, E., Sehouli, J., & Mechsner, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313102 · Cited by 62
Metadata
- Authors
- Sanchez, A. M., Vigano, P., Mugione, A., Panina-Bordignon, P., & Candiani, M.
- Venue
- Molecular Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-24
- Volume
- 18
- Issue
- 12
- Pages
- 563-571
- ISSN
- 1360-9947 (ISSN-L)
- 1460-2407
- OpenAlex
- W2126884530
- Cited by
- 35
- References
- 12
- FWCI
- 1.64
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The molecular connections between the cannabinoid system and endometriosis. https://app.cochat.ai/papers/10.1093/molehr/gas037
- The paper
- Sanchez, A. M., Vigano, P., Mugione, A., Panina-Bordignon, P., & Candiani, M. (2012). The molecular connections between the cannabinoid system and endometriosis. Molecular Human Reproduction. https://doi.org/10.1093/molehr/gas037
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.